Search results
Is Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) Expensive For A Reason? A Look At Its Intrinsic...
Simply Wall St. via Yahoo Finance· 3 months agoKey Insights Using the 2 Stage Free Cash Flow to Equity, Arrowhead Pharmaceuticals fair value...
Does Arrowhead Pharmaceuticals (ARWR) Have a Long Runway for Growth?
Insider Monkey via Yahoo Finance· 1 year agoBaron Funds, an investment management company, released its “Baron Opportunity Fund” first quarter...
Arrowhead CEO Christopher Anzalone Addresses This 'Really Important Event' In Lung Disease
Investor's Business Daily· 12 months agoArrowhead Pharmaceuticals said Thursday a single dose of its experimental drug almost completely...
Arrowhead Pharmaceuticals, Inc.'s (NASDAQ:ARWR) recent 4.3% pullback adds to one-year year losses,...
Simply Wall St. via Yahoo Finance· 2 years agoEvery investor in Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) should be aware of the most powerful...
Great week for Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) institutional investors after losing...
Simply Wall St. via Yahoo Finance· 6 months agoKey Insights Institutions' substantial holdings in Arrowhead Pharmaceuticals implies that they have...
Baron Funds: “We Retain Conviction in Arrowhead (ARWR)”
Insider Monkey via Yahoo Finance· 2 years agoBaron Funds, an asset management firm, published its “Baron Opportunity Fund” first quarter 2022...
Institutional investors may adopt severe steps after Arrowhead Pharmaceuticals, Inc.'s (NASDAQ:ARWR)...
Simply Wall St. via Yahoo Finance· 1 month agoKey Insights Significantly high institutional ownership implies Arrowhead Pharmaceuticals' stock...
Investing in Arrowhead Pharmaceuticals (NASDAQ:ARWR) five years ago would have delivered you a 982%...
Simply Wall St. via Yahoo Finance· 2 years agoArrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) shareholders have seen the share price descend 19%...
Arrowhead Pharmaceuticals Surges After Hinting At A Midstage Win In Liver Disease
Investor's Business Daily· 1 year agoArrowhead Pharmaceuticals has provided a bullish update for its midstage liver disease treatment,...
A Look At The Intrinsic Value Of Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR)
Simply Wall St. via Yahoo Finance· 1 year agoToday we'll do a simple run through of a valuation method used to estimate the attractiveness of...